文献速递妇科

FIGO 2018分期内的临床病理和影像学分层改善宫颈癌风险预测

Clinicopathological and radiological stratification within FIGO 2018 stages improves risk-prediction in cervical cancer.
PubMed 文献 · Gynecol Oncol · 2023-12-27

基于2001-2022年豪克兰大学医院948例宫颈癌患者的前瞻性队列数据,FIGO 2018分期预测疾病特异性生存的AUC为0.86,高于FIGO 2009的0.81;FIGO 2018 III期患者中原发肿瘤的范围和大小(p=0.04)及组织学类型(p=0.003)具有预后价值,Sedlis标准在FIGO 2018 IB期患者中具有预后价值(p=0.04)。

要点

  • FIGO 2018分期预测疾病特异性生存的AUC为0.86,FIGO 2009为0.81。
  • FIGO 2018较FIGO 2009最常见的分期迁移为因PET/CT和/或MRI发现可疑淋巴结而从IB/II期上调至IIIC期。
  • FIGO 2018 III期患者中原发肿瘤范围和大小(p=0.04)及组织学类型(p=0.003)具有高度预后价值。

核心结论

  • 纳入横断面影像可提高预后精确度,这与FIGO 2018指南的提示一致。
  • FIGO 2018 IIIC期可通过纳入原发肿瘤的大小、范围和组织学类型来细化。
  • FIGO IB期的风险预测可通过应用MRI评估的肿瘤大小和间质浸润来改善。

研究设计与样本

  • 数据来自前瞻性收集的患者队列,纳入2001-2022年间在豪克兰大学医院诊断和治疗的所有知情同意的宫颈癌患者(n=948)。
  • 所有患者根据个体可得数据按FIGO 2009和FIGO 2018指南进行分期。
  • 应用MRI评估的最大肿瘤直径和间质肿瘤浸润,以及组织病理学评估的淋巴血管间隙浸润,按Sedlis标准对患者进行分类。

主要发现

  • FIGO 2018分期预测疾病特异性生存的受试者工作特征曲线下面积(AUC)最高,为0.86,FIGO 2009为0.81。
  • FIGO 2018较FIGO 2009最常见的分期迁移为因PET/CT和/或MRI发现可疑淋巴结而从IB/II期上调至IIIC期。
  • 在FIGO 2018 III期患者中,原发肿瘤的范围和大小(p=0.04)以及组织学类型(p=0.003)具有高度预后价值。
  • Sedlis标准在FIGO 2018 IB期患者中具有预后价值(p=0.04)。

关键数值与推荐

  • FIGO 2018分期预测疾病特异性生存的AUC为0.86,FIGO 2009为0.81。
  • FIGO 2018 III期患者中原发肿瘤范围和大小p=0.04,组织学类型p=0.003。
  • FIGO 2018 IB期患者中Sedlis标准p=0.04。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Assess the added prognostic value of the updated International Federation of Gynecology and Obstetrics (FIGO) 2018 staging system, and to identify clinicopathological and radiological biomarkers for improved FIGO 2018 prognostication. METHODS: Patient data were retrieved from a prospectively collected patient cohort including all consenting patients with cervical cancer diagnosed and treated at Haukeland University Hospital during 2001-2022 (n = 948). All patients were staged according to the FIGO 2009 and FIGO 2018 guidelines based on available data for individual patients. MRI-assessed maximum tumor diameter and stromal tumor invasion, as well as histopathologically assessed lymphovascular space invasion were applied to categorize patients according to the Sedlis criteria. RESULTS: FIGO 2018 stage yielded the highest area under the receiver operating characteristic (ROC) curve (AUC) (0.86 versus 0.81 for FIGO 2009) for predicting disease-specific survival. The most common stage migration in FIGO 2018 versus FIGO 2009 was upstaging from stages IB/II to stage IIIC due to suspicious lymph nodes identified by PET/CT and/or MRI. In FIGO 2018 stage III patients, extent and size of primary tumor (p = 0.04), as well as its histological type (p = 0.003) were highly prognostic. Sedlis criteria were prognostic within FIGO 2018 IB patients (p = 0.04). CONCLUSIONS: Incorporation of cross-sectional imaging increases prognostic precision, as suggested by the FIGO 2018 guidelines. The 2018 FIGO IIIC stage could be refined by including the size and extent of primary tumor and histological type. The FIGO IB risk prediction could be improved by applying MRI-assessed tumor size and stromal invasion.

来源:Gynecol Oncol,查看原文。版权归原作者所有。

引用

  1. Halle MK, Bozickovic O, Forsse D, et al. Clinicopathological and radiological stratification within FIGO 2018 stages improves risk-prediction in cervical cancer. Gynecol Oncol. 2023. PMID: 38150835. doi:10.1016/j.ygyno.2023.12.014

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。